Becton Dickinson and Co had three patents in advanced materials during Q1 2024. The patent filed by Becton Dickinson and Co in Q1 2024 describes a drug delivery device with a reservoir, fluid line, delivery sub-system, insertion mechanism with a cannula, sensor to detect air in the fluid line, and control electronics to actuate the insertion mechanism. GlobalData’s report on Becton Dickinson and Co gives a 360-degree view of the company including its patenting strategy. Buy the report here.

Smarter leaders trust GlobalData

Report-cover

Data Insights Becton Dickinson and Co - Company Profile

Buy the Report

Data Insights

The gold standard of business intelligence.

Find out more

Becton Dickinson and Co grant share with advanced materials as a theme is 66% in Q1 2024. Grant share is based on the ratio of number of grants to total number of patents.

Recent Patents

Application: System and method for detecting priming of a fluid path of a drug delivery device (Patent ID: US20240009384A1)

The patent filed by Becton Dickinson and Co. describes a drug delivery device that includes a housing, reservoir, fluid line, delivery sub-system, insertion mechanism with a cannula, sensor to detect air in the fluid line, and control electronics to actuate the insertion mechanism based on the sensor signal. The device aims to ensure the safe and accurate delivery of fluids by detecting and removing air from the fluid line to prevent potential harm to the patient.

The claims associated with the patent detail additional features such as a hydrophobic membrane to expel air, positioning of the sensor relative to the membrane, use of a microcontroller in the control electronics, different configurations of the cannula, sensor types including pressure and fluid detection sensors, and various insertion mechanisms like solenoid and piezoelectric actuators. The method outlined in the claims involves delivering fluid, detecting air in the line, signaling the control electronics, and automatically moving the cannula to the extended position. Overall, the patent focuses on enhancing the safety and efficiency of drug delivery through innovative technological components and control mechanisms.

To know more about GlobalData’s detailed insights on Becton Dickinson and Co, buy the report here.

Data Insights

From

The gold standard of business intelligence.

Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.

GlobalData

GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.

GlobalData Patent Analytics tracks bibliographic data, legal events data, point in time patent ownerships, and backward and forward citations from global patenting offices. Textual analysis and official patent classifications are used to group patents into key thematic areas and link them to specific companies across the world’s largest industries.